

share
ω-Agatoxin I CAS NO 121889-77-8
Unit Price:
CAS No.:121889-77-8
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
ω-Agatoxin I is a highly selective and potent peptide neurotoxin that irreversibly blocks P/Q-type voltage-gated calcium channels. This precise mechanism of action makes it an indispensable research tool for studying neuronal signaling, synaptic transmission, and channel physiology. It is primarily utilized by neuroscientists, pharmacologists, and biochemists in academic, pharmaceutical, and biotechnology research settings.
Application
- Neuroscience Research: A critical tool for investigating the role of P/Q-type calcium channels in neurotransmitter release, synaptic plasticity, and neuronal excitability.
- Pharmacological Studies: Used to characterize and validate the specificity of novel calcium channel modulators and drug candidates in vitro.
- Cellular Physiology: Employed to dissect calcium-dependent cellular processes, including hormone secretion and muscle contraction mechanisms.
- Channelopathy Research: Facilitates the study of diseases linked to calcium channel dysfunction, such as certain forms of migraine, ataxia, and epilepsy.
- Biochemical Assay Development: Serves as a reference standard in developing high-throughput screening assays for calcium channel activity.
Basic Information
| Product Name | ω-Agatoxin I |
| CAS No. | 121889-77-8 |
| Molecular Formula | C185H274N52O55S7 |
| Molecular Weight | ~4170.8 g/mol |
| Synonyms | ω-Agatoxin I; ω-Aga-I; ω-Agatoxin IA; P/Q-type Calcium Channel Blocker; Agatoxin, ω-; Agatoxin I; FTX-3.3; Synthetic ω-Agatoxin I; Voltage-gated Calcium Channel Toxin |
| EINECS | Contact for details |
Quality Control
Our ω-Agatoxin I is produced under stringent conditions to ensure the highest standards of purity and biological activity, suitable for sensitive research applications. Each batch is accompanied by comprehensive analytical data, including mass spectrometry for sequence confirmation and HPLC for purity assessment. Certificates of Analysis (COA) detailing purity, potency, and endotoxin levels are available upon request.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store lyophilized powder at -20°C or below. Reconstituted solutions should be aliquoted to avoid repeated freeze-thaw cycles and stored at -80°C. The product is hygroscopic (moisture-sensitive); ensure the vial is equilibrated to room temperature before opening to prevent condensation.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder |
| Identification (MS) | Consistent with theoretical molecular weight |
| Purity (HPLC) | ≥ 95% |
| Potency (Biological Assay) | ≥ 98% |
| Endotoxin Level | < 1.0 EU/μg |
| Solubility | Soluble in aqueous buffers |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Bovine Albumin CAS NO 9048-46-8


Albumin From Chicken Egg White CAS NO 9006-59-1


Dermorphin CAS NO 77614-16-5


Melanotan-1 CAS NO 75921-69-6


Dsip CAS NO 62568-57-4


Humanin CAS NO 330936-69-1


Epitalon CAS NO 307297-39-8


H-Gly-Pro-Hyp-Oh CAS NO 2239-67-0


Lactoferrin CAS NO 146897-68-9


Ll-37 CAS NO 154947-66-7


Selank Peptide CAS NO 129954-34-3


Holo-Transferrin CAS NO 11096-37-0


Hyaluronidase CAS NO 37326-33-3


n-Acetyl-Phe-Octreotide CAS NO 83795-61-3


Nph-Peptide CAS NO 84311-50-2


Hirsutide CAS NO 865368-30-5


Doreptide CAS NO 90104-48-6


Neuropeptide S (1-10) (Human) CAS NO 904910-39-0


Ha Peptide CAS NO 92000-76-5


Transdermal Peptide CAS NO 918629-48-8
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






